CYTK
CYTOKINETICS INC
Key Financials
Net Income
$-784955000
↓ 33.2%
Operating Income
$-612258000
↓ 14.2%
EPS (Diluted)
$-6.54
↓ 24.3%
Revenue
$88.0M
↑ 376.6%
Total Assets
$1.4B
↑ 1.6%
Cash & Equivalents
$122.5M
↑ 29.2%
Shareholders' Equity
$-659625000.00
↓ 387.3%
Total Liabilities
$2.1B
↑ 35.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/22/2026 | View on SEC |
| 144 | 9/15/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 4 | 9/15/2026 | View on SEC |
| 4 | 9/11/2026 | View on SEC |
| 144 | 9/11/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/1/2026 | View on SEC |
| 144 | 9/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYTK |
| Company Name | CYTOKINETICS INC |
| CIK | 1061983 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (650) 624-3000 |